Salix is broke

Discussion in 'Salix' started by anonymous, Jan 24, 2020 at 12:21 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    In case you haven’t noticed, we are being squeezed hard for every nickel lately. Fewer people hitting bonus every quarter. Massive sales goal increases. Hiring freezes. Loss of patent on important brands. Collapsed co-promotions. This company is in a serious financial tailspin. Don’t buy into the hype about record breaking Xifaxan sales. Trulance and Plenvu aren’t making money. Xifaxan alone is not enough to keep us afloat.
     

  2. anonymous

    anonymous Guest

    Are you really that ignorant....?
     
  3. anonymous

    anonymous Guest

    Are you? Keep drinking that kool aid.
     
  4. anonymous

    anonymous Guest

    Soooo stupid STFU you idiot!
     
  5. anonymous

    anonymous Guest

    Hey Dumbass....
    I’m not saying that they havent cut payouts- but to say that the company is not making money based on your comments is ridiculous.
    For one - they had already budgeted for potential loss of patents. (This was expected), And more importantly ALL products are growing.

    Since you seem somewhat clueless: Attainment does not equal growth... It equals payout, which sucks lately, but this too will change. For now Im making them pay me back through the ESPP, but you probably think thats a rip off right?

    JC needs to get the IC plan / quotas right so we are paid for what we sell, but to say that the company is not making money just shows how uneducated you are regarding all of this.
     
  6. anonymous

    anonymous Guest

    Fuck Salix. I hope this place burns to the ground. And yes, I’m a current employee here.
     
  7. anonymous

    anonymous Guest

    Hey Fuckweasel.

    Yes the company is making money. Yes the products, what’s left of them, are growing. But they aren’t growing fast enough to replace the revenue lost by Uceris and Apriso which combined brought in almost $500mm annually. And don’t tell me how leadership “budgeted for that.” We haven’t replaced that revenue. Trulance isn’t moving. We have not made plan one single quarter since we bought Synergy. And we make no money on Plenvu. The deal with Dova? Failure. The deal with US Worldmeds? Dead in under a year. Leadership hasn’t done much right in a long time.

    BHC is desperate to report winning numbers to Wall Street. Price increases bolster the measly single digit prescription growth rates for Xifaxan so Papa can say we broke an all time record. Valeant proved you can only get away with that for so long. Do you ever wonder why it’s taking so long to replace McKenna? It’s because nobody worth their salt wants the job. He ran from here and sold all his stock on the way out. Yeah. I’m sure that’s nothing to be concerned about.

    And personally, I don’t give a fuck about company growth if they are cutting our payouts to get there. Look at the weekly reports. Count the number of reps and districts actually at plan. The forecast is a joke and has been for three years. They manipulate the IC plan with all sorts of conditions to make sure we can’t blow it out.

    So you keep on buying that BHC stock buckaroo. Tell yourself it’s all going to be OK. I guarantee, Salix will look very different in about 12 months.
     
  8. anonymous

    anonymous Guest

    Salix burned to the ground the day we became Valeant.
     
  9. anonymous

    anonymous Guest

    BHC is broke as fuck. A number of analysts say the company is at risk of bankruptcy as the latest round of bond payments loom large. BHC owns Salix. Do the math.
     
  10. anonymous

    anonymous Guest

    Are you reading news from 2 years ago?
     
  11. anonymous

    anonymous Guest

    No. December 17th, the company effectively borrowed another $1.25 billion to prepare for upcoming legal fees and settlements related to securities lawsuits. This effectively kicks the can down the road another five years. But it doesn't lower the debt. In fact, BHC is borrowing money to pay the settlements. I thought BHC had a mountain of cash on hand? At least the interest on the loan is cheap at a little over 5%.

    https://seekingalpha.com/news/3526721-bausch-health-launches-1_25b-debt-offering
     
  12. anonymous

    anonymous Guest

    Again - are you ignorant?
    Seeking Alpha as a source ? Too comical...
     
  13. anonymous

    anonymous Guest

    You are associating making plan with revenue? Those goals often include 30% growth. 20% growth may be below plan - but far from a loss.
    Try listening to an earnings call. And yes - it has been known for years that we would lose Apriso/ Uceris - it is included in projected earnings. Trulance revenue was also not previously included. Do some simple research beyond seekingalpha.
    Also Say what you want about the stock - but an extra 20K / year with the match works for me- easy $$$.
     
  14. anonymous

    anonymous Guest

    So because the headline came from seeking alpha, that means BHC didn’t take in additional debt to pay legal fees and lawsuits related to putative securities violations? Because they did. But whatever.
     
  15. anonymous

    anonymous Guest

    I broke your ol lady
     
  16. anonymous

    anonymous Guest

    Of course they took in additional debt to pay those... These fees /fines were inevitable. The fact is that most analysts saw this move as a positive- It cleared the uncertainty and lowered the interest rate. This is another positive step that Papa has taken to reduce the overall debt ratio as he promised.
     
  17. anonymous

    anonymous Guest

    The way I see it - we are far from broke as the thread starter states- but obviously we still have a ton of debt. Its just a smaller ton than it was, which all things considered is a good thing. We will see what the analysts think on the next call. So far they seem to be happy with the progress. Thats what really matters.
     
  18. anonymous

    anonymous Guest


    Just curious. Do most participate in the the ESPP? And if so, how many do the max %? Most companies only offer ESPP discounts....BHC offers a sizable match. Timing is always key....surely the legacy reps got burned on this program during Valeants tumble from grace. But if you've been here for 3 years give or take, its definitely paid off.
     
  19. anonymous

    anonymous Guest

    Its very hard to lose with this - even legacy didnt get burned too bad. The 75 match per dollar insures that. The problem was, back then it took 3 years for it to vest, now its only 1 year, that is a huge difference. I think most feel like they cant afford to max out the espp. Think of it this way, In 1 year you can sell what vests and get back your 20% plus the .75 match. Its an easy win - even if you might have to charge some debt during that year to get by. Then you can pay off the credit cards with your “free” $$ match, even with the CC interest you are way ahead. Once you hit a year you have some vesting every quarter so its relatively easy to get caught back up. But - you have to be willing to hit the trigger and wait it out a year... to get the big return you have to max it out at 20% and take full advantage of the match.
     
  20. anonymous

    anonymous Guest

    Truth!